Find uplifting stories about heroes, innovations, and solutions
3700 results for "crispr gene therapy"
A Pennsylvania baby born with a deadly genetic disorder is now thriving after doctors created the world's first personalized CRISPR treatment just for him. Baby KJ can now eat protein and has stopped all medications after three doses of the groundbreaking therapy.
A Pennsylvania baby born with a deadly rare metabolic disorder is now thriving after doctors created the world's first personalized CRISPR gene therapy just for him. Six-month-old KJ can now eat protein and stopped all medications after three doses corrected his faulty gene.
Children as young as 2 can now access a breakthrough gene therapy that could eliminate the need for lifelong blood transfusions. The FDA just expanded approval of Casgevy, a one-time CRISPR treatment that edits a patient's own cells to fight sickle cell disease.
Children as young as 5 can now benefit from groundbreaking CRISPR gene therapy for severe blood disorders. New research shows the treatment works safely in younger kids, potentially preventing years of disease complications.
A groundbreaking gene-editing treatment could reach patients faster than ever before, as Prime Medicine asks the FDA to approve their therapy after just two successful treatments. The drug uses a revolutionary CRISPR technique to fix a genetic disorder that leaves patients vulnerable to deadly infections.
Austin Louis spent his entire life in excruciating pain from sickle cell disease until a revolutionary gene therapy treatment made him feel like "a new human." The 20-year-old New Jersey man became the first patient at Children's Hospital of Philadelphia to receive the FDA-approved CRISPR treatment outside clinical trials.
A groundbreaking gene therapy trial has achieved what doctors call a "functional cure" for sickle cell disease, eliminating painful crises in 27 out of 28 patients. The one-time treatment uses gene editing to fix the blood disorder that has killed patients decades too soon.
%2Cfit(1200%2C675)%2Cquality(65))
Children as young as two can now receive a groundbreaking gene therapy that offers a potential cure for sickle cell disease. The FDA's approval of Casgevy marks a historic expansion that could prevent irreversible damage before it starts.
)
A single gene-editing treatment could replace daily cholesterol pills for millions, after early trials showed one infusion cut dangerous LDL levels by 62% for up to 18 months. Scientists used CRISPR technology to modify how the body naturally clears cholesterol from blood.
A PhD student at MIT is developing a breakthrough gene therapy for children with SYNGAP1 disorder, a rare genetic condition that causes seizures starting as young as 4 months old. Early tests in mice have eliminated seizures completely.
Researchers at Texas A&M have developed a way to control gene editing with caffeine, potentially allowing cancer and diabetes patients to activate treatment by drinking coffee. The breakthrough combines CRISPR technology with everyday compounds like caffeine and chocolate.
Scientists have begun testing a breakthrough gene therapy that could restore hearing for people with the most common genetic cause of deafness. Skylark Bio just dosed their first patient, marking a major step toward helping millions born with this genetic mutation.
A Louisiana man with lifelong sickle cell disease received groundbreaking gene therapy that eliminated his symptoms and opened the door to his dream career as a pilot. His story represents hope for thousands living with this painful genetic condition.
Scientists are building a system to make life-saving gene therapy accessible to the 400 million people living with rare diseases worldwide. The new Center for Therapeutic Genetics wants to turn custom genetic medicine into a standardized procedure that can help patient after patient.
Twenty-seven out of 28 patients with severe sickle cell disease are now living pain-free after a groundbreaking gene editing treatment. The one-time therapy is offering new hope to people living with a genetic disorder that typically shortens life expectancy to the mid-40s.
A breakthrough gene editing treatment has achieved what doctors call a "functional cure" for sickle cell disease, with 27 out of 28 patients experiencing zero painful crises after receiving the therapy. The one-time treatment edits patients' own blood cells to correct the genetic mutation, offering new hope for 100,000 Americans living with this painful disease.
A groundbreaking gene therapy has reversed blood cancers once considered untreatable, with seven of eleven patients still disease-free three years later. The world-first technique transforms donor white blood cells into a "living drug" that hunts cancer.
Children born completely deaf are hearing whispers for the first time thanks to an experimental gene therapy that has shown remarkable success in the largest study of its kind. The treatment could become the first FDA-approved gene therapy for deafness within months.
After becoming the first country to approve a revolutionary gene-editing therapy in 2023, the UK is now using Casgevy to treat patients with sickle cell disease and β-thalassaemia. The treatment has shown remarkable results, freeing 97% of sickle cell patients from painful episodes for over a year.
Melbourne researchers developed an AI tool that creates molecular "off switches" for CRISPR gene editing in just 8 weeks. The breakthrough could help make gene therapy treatments safer and more accessible for patients with genetic diseases.
Showing 20 of 3700